COMPANY
RefleXion Medical
Timeline
- FDA FDA 510(k) clearance: RefleXion Medical Radiotherapy System, Reflexion X2 — K252071, Dec 18, 2025. Applicant at approval: Reflexion Medical, Inc. source ↗
- Trial start Not phased (device or behavioral study): SCINTIX [BgRT} Using RMRS in Solid and Soft Tissue Tumors source ↗
- Trial start —: Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System source ↗
- Trial start Not phased (device or behavioral study): Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X) source ↗
Upcoming milestones
- Jan 1, 2027 (ESTIMATED) · Not phased · SCINTIX [BgRT} Using RMRS in Solid and Soft Tissue Tumors · NCT06634706
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05406167 | Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System | Not listed | Recruiting | Apr 12, 2022 | Apr 25, 2026 (estimated) |
| NCT06634706 | SCINTIX [BgRT} Using RMRS in Solid and Soft Tissue Tumors | Not phased (device or behavioral study) | Not yet recruiting | Dec 1, 2025 | Jan 1, 2027 (estimated) |
| NCT04788147 | Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X) | Not phased (device or behavioral study) | Completed | Mar 26, 2021 | Dec 20, 2021 (actual) |
FDA records (last 2 years)
- FDA 510(k) clearance: RefleXion Medical Radiotherapy System, Reflexion X2 — K252071, Dec 18, 2025. Applicant at approval: Reflexion Medical, Inc. source ↗
NIH awards 7
- NIH award 5R44CA228753-03 FY2020: $950,000 awarded for that fiscal year; activity R44 (SBIR); PI MAZIN, SAMUEL; recipient as written: REFLEXION MEDICAL, INC., HAYWARD, CA. Pre-clinical validation and verification of source ↗
- NIH award 4R44CA228753-02 FY2019: $1,050,000 awarded for that fiscal year; activity R44 (SBIR); PI MAZIN, SAMUEL; recipient as written: REFLEXION MEDICAL, INC., HAYWARD, CA. Pre-clinical validation and verification o source ↗
- NIH award 1R44CA228753-01 FY2018: $300,000 awarded for that fiscal year; activity R44 (SBIR); PI MAZIN, SAMUEL; recipient as written: REFLEXION MEDICAL, INC., HAYWARD, CA. Pre-clinical validation and verification of source ↗
- NIH award 5R44CA153466-04 FY2016: $66,210 awarded for that fiscal year; activity R44 (SBIR); PI MAZIN, SAMUEL; recipient as written: REFLEXION MEDICAL, INC., HAYWARD, CA. Rotating PET and linear accelerator system fo source ↗
- NIH award 5R44CA153466-03 FY2015: $264,232 awarded for that fiscal year; activity R44 (SBIR); PI MAZIN, SAMUEL; recipient as written: REFLEXION MEDICAL, INC., HAYWARD, CA. Rotating PET and linear accelerator system f source ↗
- NIH award 2R44CA153466-02A1 FY2014: $1,169,548 awarded for that fiscal year; activity R44 (SBIR); PI MAZIN, SAMUEL; recipient as written: REFLEXION MEDICAL, INC., HAYWARD, CA. Rotating PET and linear accelerator syst source ↗
- NIH award 1R43CA153466-01A1 FY2011: $260,006 awarded for that fiscal year; activity R43 (SBIR); PI MAZIN, SAMUEL; recipient as written: REFLEXION MEDICAL, INC., HAYWARD, CA. Real-time PET guided radiation therapy for source ↗
Connect
See your connections at RefleXion Medical on LinkedIn (search by name, results not checked)